David Jenkins is a consultant medical microbiologist and infection prevention doctor at University Hospitals of Leicester NHS Trust (UHL), and Associate Professor at the University of Leicester, both in the UK. He is also the president of the British Society for Antimicrobial Chemotherapy (BSAC).
Over the last 25 years, his career has mostly focussed on tackling multi-drug resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum beta-lactamase (ESBL) producers as well as carbapenemase-producing Enterobacterales through the development and implementation of infection prevention measures and antimicrobial stewardship interventions. David has also joined colleagues in social science at the University of Leicester in behavioural research projects, including an international investigation of prescribing practice funded by the Economics and Social Research Council.
Major themes of his presidency at BSAC are to support for the development of microbiology laboratory capacity in low and middle-income countries and the establishment of a scheme to accredit antimicrobial stewardship practice which aims to identify and resolve barriers to improvement in prescribing practice.